Regulatory GuideOctober 10, 2026 · 22 min read · VEMERIX

A Thai Device Importer Registration Is Not Product Authorization

Verify a Thai partner's establishment, product and shipment documents before committing to a sterile-device launch.

Thailand Market AccessDistributor Due DiligenceMedical Device RegistrationSterile Single-Use Devices
Diagram showing the three Thai medical device authorization layers: importer establishment registration, device product certificate, and shipment License per Invoice.

The distributor onboarding dilemma: what does 'registered' actually mean?

Consider a manufacturer preparing circumcision staplers, medical laser fibers or NPWT dressings for a Thai distributor. The partner sends an establishment certificate and says it is already registered with Thai FDA. That is a useful starting document, but it does not answer whether the proposed devices can be marketed or whether the next consignment has its required import paperwork. The question is what the certificate actually covers for this proposed launch.

Thai FDA's commercial-import overview separates establishment registration, device risk classification and product registration. Its import guideline then adds LPI, customs declaration and checkpoint inspection. Read these as distinct checks, rather than accepting the word 'registered' as a complete answer. 4 6 The same distinction is useful when reading Singapore's dealer-licence and product-listing requirements, although Thai forms and conditions must be verified independently.

This guide is for export managers, distributor teams and procurement staff deciding what evidence to request before signing or dispatch. It turns the official pages into a partner-verification file. It does not classify a VEMERIX product for Thailand, establish a filing route for a particular model, or replace the local applicant's regulatory assessment. A missing document should produce a named owner and a resolution step; it is not by itself evidence of bad faith.

What does a Thai importer establishment registration actually cover?

Thai FDA says anyone manufacturing or importing medical devices for commercial purposes must register the establishment. Its Thai establishment page uses registration terminology and the importer form series ส.น.; the English overview calls the step 'Establishment Licensing'. These labels refer to the establishment layer. Do not infer a product authorization from either English term. New importer applications use สน.1 through the Skynet submission system. 1 2 4

For partner due diligence, check the following parts of the establishment file. The official application documents show what Thai FDA asked for; the operational questions are buyer checks layered on top of that record.

  • Applicant and registered address. Thai FDA's page requires a person or juristic person commercially registered with the Department of Business Development, with relevant device business objectives and the importing address recorded in company information. Branch arrangements need the additional evidence identified by the authority. Do not substitute a trading name for the legal applicant. 1
  • Import and storage locations. The new-importer page provides different map and photograph forms for import and storage at the same or different locations. It also lists storage consent letters and annexes for multiple storage sites. Ask which locations are actually used, including any third-party warehouse, then match them to the establishment file. 2
  • Storage suitability. Ask the partner how it will meet the selected device's labeled storage conditions and handle damaged or suspect lots. Temperature monitoring, stock segregation and escalation records are useful evidence requests where relevant. The establishment application records the premises; it does not certify how a particular device will be handled later. 2
  • Controller and authorized applicant. The official page lists import-controller documents and an annex where more than one controller is declared. Request the current appointment evidence and identify who submits applications and who answers regulatory queries. A salesperson's assurance does not establish that those roles are currently covered. 2

For a new importer establishment application, the official page lists 100 THB for the application, 12,000 THB for assessment and 4,000 THB for the certificate: 16,100 THB in total. It states 30 working days counted from filing, plus a five-working-day assessment-payment step; it also warns about returned applications and permits one document correction. Treat this as published process information, not a statutory minimum delay or an end-to-end launch guarantee. 2 4

Request the current certificate and supporting scope or location documents rather than only the original application. Compare the legal name, importing address, declared storage sites and expiry with the proposed arrangement. If something changed after grant, ask for the authority's amendment or current record. The certificate alone is not evidence that every model in the supplier's catalogue has completed product registration. Thai FDA announced revised establishment forms with clearer location, contact and responsible-person information on 5 March 2026; obtain current templates instead of recycling an older partner file. 5

LayerWhat to verifyPublished fees or cost boundaryExpiry or shipment boundary
Importer establishmentLegal operator, importing address, storage documentation and controller; new application สน.1. 1 216,100 THB new application total; separate from product registration. 2 4Five-year validity framework; use the printed 31 December expiry year and the renewal record. 3
Product certificateDevice or authorized group covered by listing, notification or licensing, with the relevant holder and manufacturer. 4 7Published import totals: Class 1 3,100 THB; Classes 2–3 49,000 THB; Class 4 74,000 THB. Confirm the applicable evaluation route and expert-fee treatment. 4Read the actual certificate and its applicable renewal requirements. The cited product-renewal page concerns licences and detailed-notification receipts. 8
License per InvoiceLPI for each import, followed by customs declaration and checkpoint inspection. 6 14The cited pages publish no LPI fee; ask the agent for an itemized current shipment quote.Keep the LPI with that import file; it is not a standing product authorization. 6 14
Table 1: Three separate checks for an ordinary commercial import

Source: Buyer synthesis of Thai FDA establishment, commercial-import and checkpoint pages; reviewed 10 October 2026.

When does handling in Thailand become manufacturing rather than importing?

The proposed work in Thailand matters as much as the certificate heading. Write down whether the partner will store and distribute finished devices, change packaging, assemble a kit, alter labels or arrange sterilization. Provide photographs or a packaging diagram where the words 'repack' or 'relabel' leave room for different interpretations. The regulatory assessment should concern the actual operation, not a vague service description.

Thai FDA's establishment page expressly includes producing, assembling, dividing or combining packaging, modifying devices and making devices sterile in its description of manufacturing. Those activities warrant review of the manufacturing establishment and product requirements. The page does not decide every transport-carton or supplementary-label scenario, so avoid treating all handling as manufacturing or all external labeling as permitted. 1

  • Distinguish logistics from device packaging. Removing intact retail units from a transport carton is not enough evidence to declare a manufacturing operation. Identify which packaging level changes, whether the marketed unit changes, and whether approved labels or the sterile barrier are affected. Ask the local regulatory lead to resolve the boundary before work begins.
  • Describe kit assembly precisely. Combining device packaging or assembling devices appears in Thai FDA's manufacturing definition. Specify every component, the kit's intended use and the responsible establishment; do not assume importer registration alone covers the resulting arrangement. 1
  • Keep sterilization within its assessed scope. Sterilizing is expressly a manufacturing activity on the official establishment page. Confirm who performs it, where, and which authorization and product evidence cover the process. 1
  • Confirm the labeling plan. For a proposed Thai supplementary label, describe the text, package surface, responsible party and approval process. The checkpoint guidance requires compliance with applicable labeling notifications; preserving the sterile barrier does not, by itself, prove that a particular relabeling operation is authorized. 14

Use an unresolved activity boundary as a hold point for that work. Obtain a written assessment from the local applicant or Thai FDA identifying the establishment category and any product or labeling changes needed. Keep that assessment with the distribution agreement. If noncompliance is suspected, obtain a case-specific assessment of the legal and shipment consequences; a definition page alone does not establish the applicable sanction.

Proposed activityWhat the sources establishEvidence to request before the work
Store and distribute intact finished devicesCommercial imports need establishment and product checks; the storage file is part of the establishment application. 2 4Match actual import and storage addresses, product scope and labeled storage conditions.
Open a transport carton to pick intact sale unitsNot expressly addressed by the manufacturing definition.Identify every packaging level and show that the marketed unit, labels and sterile barrier are unchanged; resolve any uncertain boundary.
Apply a Thai supplementary labelCheckpoint labels must comply with applicable Ministry notifications; no blanket permission is established here. 14Confirm final artwork, location of the label, applicant responsibility and the applicable authorization assessment.
Divide/combine device packaging or assemble a procedure kitDividing or combining packaging and assembling are included in manufacturing. 1Manufacturing-category review, responsible establishment and product/kit scope; verify the particular operation.
Sterilize or modify devices locallyBoth sterilizing and modifying appear in the manufacturing definition. 1Identify the performing site and the authorization, process evidence and release responsibilities applicable to it.
Table 2: Local handling questions that change the evidence request

Source: Buyer interpretation of Thai FDA establishment definitions and checkpoint guidance; not a case-specific classification ruling.

What authorizes the device itself, and in whose name?

Thai FDA's overview uses four risk classes. Its general certificate structure is listed for Class 1, notified for Classes 2–3 and licensed for Class 4. The applicant must first establish the actual device classification and grouping; specially regulated devices may have additional requirements. Do not classify a stapler, dressing, laser fiber or adhesive from its category name, sterility or foreign certificate alone. 4 7

  • Class 1 listing. The official overview lists an import total of 3,100 THB. Its dossier checklist includes specifications, label, instructions and other evidence, including a sterilization report where applicable. Low risk is not synonymous with non-sterile, and listing is still a product step. 4
  • Classes 2–3 notification. The overview lists an import total of 49,000 THB, including an expert-fee component. Full, Abridged and HSA-reliance dossier columns differ. Ask which route applies and whether the listed fee components apply to that route. 4
  • Class 4 licensing. The overview lists an import total of 74,000 THB, including expert review. This is a published regulatory fee total, not the cost of testing, translation, representation or the complete launch. 4

For an imported product, reconcile the local applicant or holder named in the product record with the importing arrangement, the manufacturer's authorization and the devices to be supplied. The official dossier lists a Letter of Authorization and allows a device list and grouping where applicable. One certificate may therefore cover an authorized group: a different commercial SKU does not automatically imply a separate application. Verify the covered models and variants rather than demanding a certificate count equal to the purchase-order line count. 4

Record the device trade name, model or variant list, intended use, manufacturer and holder against the proposed shipment. If the local seller is different from the named importer or holder, document the roles and the authorized supply arrangement. A certificate held by another entity is a question to resolve, not automatic evidence that the arrangement is invalid.

Changing Thai partners: dossier transfer needs its own assessment

English consultancy summaries give different impressions: Andaman says product-licence ownership transfer is not permitted, Qualtech describes a dossier Transfer process, and Asia Actual discusses transferability in relation to the original submission. These are secondary summaries, not conflicting regulatory rulings. The distinction between transferring a dossier through an application and freely assigning an existing certificate matters. 11 12 13

  • Start with the official process. Thai FDA publishes a Transfer page for licensed and detailed-notification medical-device applications. It calls for a Full CSDT application using transferred documents, updated conformity and authorization documents, identicality, consent and safety declarations. This is more specific than either a blanket 'never transferable' or 'freely transferable' answer. 10
  • Check the original file. The page describes supplementation where the original dossier is Partial. Confirm the original registration, document format, current status and whether the proposed change meets the process conditions before planning the handover. Do not extend this page's scope automatically to Class 1 listings. 10
  • Plan the old registration's closure. After approval of the transferred application, the official page says the original registration is cancelled and its holder must complete the relevant withdrawal documents within 30 calendar days. Build the handover around the authority's decision and the required consent, rather than a promised change of name on a certificate. 10

Agree who may access the dossier, who supplies signatures and consent, who pays for supplemental evidence, and who maintains supply during the transition. Include a fallback if the requested route is unavailable. These are commercial planning recommendations, not mandatory contract clauses prescribed by the cited page. A contract cannot compel the authority to accept an ineligible transfer or create access to confidential records that has not been agreed.

Evaluation routes can change the file, but do not replace Thai authorization

The official English overview distinguishes Full, Abridged and HSA-reliance dossiers. Abridged evaluation asks for reference-agency approval evidence; the HSA route includes HSA approval and participation documents. Ask the local applicant to identify the exact eligibility and required file for the device. The cited overview does not establish an end-to-end product-approval duration; obtain a current route-specific assessment before setting the launch schedule. 4

The Malaysia–Thailand joint announcement dated 1 May 2026 moved the reliance programme to full implementation for the stated Class B, C and D scope. For the Thai side it describes bypassing external expert evaluation using MDA approval with a full CSDT submission; the Malaysian verification route is a separate direction. The announcement references a draft Thai notification; confirm the finalized Thai implementation and device eligibility before relying on this route. Reliance changes evaluation, not the need to complete Thai authorization or verify the importer. 9

What moves each shipment through Thai customs?

For ordinary commercial imports, Thai FDA's English guideline and the checkpoint division's Thai page require an LPI for each import. That transaction sits alongside the establishment and product records. Holding the two certificates does not replace the LPI or the subsequent customs and checkpoint procedures. 6 14

Use the official sequence to assign responsibilities. Ask the importer or agent to demonstrate the workflow and confirm the current filing fields for your shipment. The readiness checklist below identifies the evidence to collect before relying on the arrangement.

  1. Resolve the permissions first. Check the importing establishment and the product permission covering the intended devices. Assign the importer of record and identify the authorized agent. 6 14
  2. Prepare the LPI. Thai FDA says to obtain it on each import; the English page describes operator or agent access using a national ID number. Have the responsible applicant reconcile its current LPI requirements with the shipping documents. Resolve model or naming discrepancies before filing; confirm the actual system requirements with the applicant. 6
  3. Arrange checkpoint authority and customs declaration. The checkpoint division includes submission of the power of attorney for checkpoint procedures and preparation of the customs import declaration. Record who completes each action and where the goods will enter. 14
  4. Keep the checkpoint file available. The official list includes the import declaration or international-parcel notice, invoice or transport document, LPI and a device sample for inspection. The English guideline also lists checkpoint power of attorney. Label examination follows applicable Ministry notifications; use the exact device requirements for the selected device and intended user. 6 14

Before dispatch, agree a readiness decision with the importer and freight agent: product scope confirmed, LPI preparation assigned, inspection documents available and storage arrangements suitable for the labeled conditions. An LPI is not a guarantee of release. If questions remain, identify the missing evidence and obtain the authority's clarification. Plan suitable storage during any inspection or clearance delay.

Which expiry windows can strand a launch mid-onboarding?

The establishment-renewal page states five years from authorization, with expiry on 31 December of the expiry year. Use the date printed on the partner's certificate rather than calculating a fifth anniversary yourself. The ordinary renewal submission window is 1 October–31 December of the expiry year. 1 3

As reviewed on 10 October 2026, the page's current cycle heading gives 1 October–31 December B.E. 2569 (2026), with late filing during 1–31 January B.E. 2570 (2027). The next sentence still says the system closes on 31 January '69' at 23:59, which appears to be carried over from the previous cycle. Confirm the closing time on the current portal notice rather than relying on either line alone. 3

Budget and file for the renewal as well as the deadline. For an importer establishment the renewal page lists a 12,000 THB renewal assessment charge and a 4,000 THB certificate fee, both payable on the filing day. For the 2026 cycle it also publishes a supplementary-information form (สน.4) to bring the file into line with the new notification dated 1 May 2026 (B.E. 2569), alongside an updated renewal preparation manual. Ask a partner renewing this year whether that supplementary filing applies to its establishment and whether its declared sites and controllers are being updated at the same time. 3

WindowPublished ruleBuyer verification step
1 October–31 December of expiry yearOrdinary renewal window. The page requires renewal assessment and certificate fees to be paid on the filing day for completion. 3Obtain completed filing/payment evidence and current status; a prepared form alone is not a completed renewal.
Within one month after expiryLate renewal is possible with a 500 THB daily fine while no renewal application has been filed. Do not treat this as unconditional permission to continue operations. 3Ask the holder to confirm accepted renewal, payment and authority status before relying on shipment readiness.
More than one month after expiryThe page says renewal is unavailable. It does not describe the consequences for linked product records or how long a fresh application takes. 3Resolve the required fresh establishment application and product/shipment consequences with Thai FDA before resuming the plan.
Table 3: Establishment renewal checkpoints

Source: Thai FDA establishment-renewal page, read 10 October 2026. Current portal notices should resolve its inconsistent older closing-year line.

For a partner whose establishment expires at the end of 2026, add a named renewal owner and documentary due date to the onboarding plan. Keep filing and payment evidence together and revisit the plan if either is missing. Do not infer uninterrupted import capacity from having uploaded a form, or infer that a late-filing option is an unrestricted operating grace period. 3

An expired establishment creates a material readiness question because commercial import requires establishment registration. Confirm the authority's current status before committing stock. The cited pages do not describe what happens to linked product certificates or pending shipments, so obtain that answer from the authority for the specific case. Keep the legal status and the practical shipment decision separate. 3 4

Product renewal requires a separate calendar. The official product page, dated 22 July 2025, concerns licences and detailed-notification receipts and says its renewal system opens 1 October–31 December each year. That is an annual filing window, not evidence that every product certificate lasts one year or that Class 1 listing follows the same renewal rules. Check the actual product record and current instructions. 8

What should you verify in a Thai partner's paperwork before signing?

Use this checklist as a request schedule before exclusivity or first dispatch. Thai FDA's new-importer page supplies the establishment document anchors; product and checkpoint pages supply the other layers. The commercial rows are editorial recommendations. Record an owner, evidence date and open question for every row rather than accepting a single 'FDA registered' tick box. 2 4 14

CheckpointDocument or record to requestDecision test / unresolved question
1. Importer establishmentCurrent certificate, relevant endorsements and renewal evidence. 1 3Match legal holder, importer activity, importing address and actual expiry. Seller permission alone does not demonstrate importer registration.
2. Corporate alignmentDBD information and branch evidence where applicable. The new-importer page specifies a company affidavit within six months for the stated non-head-office case. 1 2Match legal identity, business objectives and importing address. Keep a storage address separate from the importing-office test; different locations are expressly contemplated.
3. Import and storage sitesMaps EST-F-I-05-01/-02; photographs EST-F-I-06-01/-02; applicable storage consent EST-F-IMS-08-01/-02 and multiple-storage annex. 2Match the actual locations and signed arrangements. Ask whether a proposed new or overflow site needs an amendment; request handling evidence suited to this device.
4. Controller and applicantCurrent import-controller documents, appointment evidence, and multiple-controller annex where applicable. 2Who covers each role now, and what happens if a named person changes?
5. Authorized device scopeProduct certificate and device/model or grouping list; manufacturer authorization and applicable labels. 4 7Does the record cover every intended variant and use? Who is the holder, importer and local seller? Resolve differences before relying on it.
6. Import executionShipment LPI plan, agent authority, checkpoint file; a redacted prior record if useful. 6 14A past LPI demonstrates experience, not permission for this shipment. Identify the responsible agent and confirm the current entry requirements.
7. Local handlingWritten description of packaging levels, label work, assembly or sterilization. 1 14Obtain the activity-category assessment before the work. Preserve the marketed unit and sterile barrier while the decision is unresolved.
8. Continuity and contractRenewal responsibility, dossier-access agreement and a transfer assessment against Thai FDA conditions. 3 10Agree cooperation, evidence costs and fallback options. A transfer covenant does not guarantee approval; neither exclusivity nor its absence proves dossier control.
Table 4: Thai partner verification request schedule

Source: Buyer synthesis of the official establishment checklist, product requirements, renewal and transfer pages; contract and readiness questions are recommendations.

Separately check manufacturer-side evidence before the local applicant uses it. The guide to verifying a certificate of free sale explains that document's limits; the guide to checking an ISO 13485 certificate's scope covers quality-system evidence. Neither document replaces a Thai product certificate. Keep the dossier requirements specific to the selected route. 4

Where VEMERIX fits—and where due diligence still begins

VEMERIX is the international brand of Weihai Medison Medical Equipment Co., Ltd., positioned as a Minimally Invasive Surgery Total Solution Platform serving urology, vascular surgery and perioperative care.

  • Urology: the related circumcision-stapler product is a sterile single-use portfolio example for which the intended Thai model scope and local handling should be checked.
  • Vascular consumables: Medison's single-use medical laser fiber is used with a partner-supplied diode laser source. The console's supplier and authorization are separate questions; the fiber does not establish authorization for the complete system.
  • Perioperative consumables: the related NPWT dressing kit is another portfolio example. Confirm the selected variant and intended use with the product documents; this guide assigns no Thai class or registration status.

For a proposed Thai distribution project, request the current product-specific technical pack and an availability review of the documents your local applicant requires. Identify missing tests, translations or authorizations before agreeing a filing plan. This article does not certify that every product has a complete Thai CSDT, a certificate of free sale or Thai marketing authorization, and it does not promise a registration service or approval outcome.

Send the target device and variants, intended use, proposed Thai applicant or holder, import and storage sites, planned local handling and launch constraints through a Thai distributor documentation enquiry. Ask which current documents can be supplied and what still needs confirmation. The related product cards below support specification review; they are not evidence of Thai authorization.

Frequently asked questions

Our distributor is registered with Thai FDA. Can it import our devices immediately?
The establishment certificate alone is insufficient. Verify product authorization covering the device or group and the responsible local holder/importer arrangement. The ordinary commercial-import procedure also requires LPI and customs/checkpoint steps. Do not infer a separate certificate for every SKU where an authorized group applies. 4 6

Can an overseas manufacturer simply use its home-country registration?
No. Thai FDA's commercial-import procedure has a local establishment and product layer. Request the eligible local applicant's evidence and manufacturer authorization; assess a proposed corporate structure separately rather than making a blanket nationality or incorporation claim from this guide. Foreign approvals may support an eligible evaluation route but do not replace Thai authorization. 1 4

Can a product file move to another Thai partner?
Thai FDA publishes a document-transfer application process for licensed and detailed-notification devices, with Full CSDT, consent and other conditions. Verify the exact file and change against that process. It is not unrestricted assignment of an existing certificate, and the page does not establish a Class 1 transfer route. 10

Does importer registration cover repacking in Bangkok?
Thai FDA includes dividing or combining device packaging, assembling, modifying and sterilizing within manufacturing. Identify what changes and have the local regulatory lead confirm the required category. Ordinary transport-carton opening and supplementary labels need their own factual assessment; preserving the sterile barrier is not a blanket permission to relabel. 1 14

What if the establishment misses the year-end renewal window?
The official page permits renewal within one month after expiry, with a 500 THB daily fine while renewal has not been filed. It requires filing-day payment for completion and says renewal is unavailable after more than one month. Confirm current authority status and the next application before scheduling supply. 3

Can the Vietnam importer checklist be reused for Thailand?
Reuse the discipline of assigning document owners, not the national forms or permissions. Thailand's establishment, product and LPI checks must be evidenced under Thai requirements. The Vietnam first-shipment document guide addresses that market's circulation, authentication and labeling file; keep the country files distinct.

Sources

  1. Thai FDA Medical Device Control Division — Establishment registration (import/manufacture): definitions, form series and DBD requirements (Thai)
  2. Thai FDA Medical Device Control Division — New importer establishment registration: สน.1 document checklist, fees, timeline (Thai)
  3. Thai FDA Medical Device Control Division — Renewal of establishment registration certificate: validity, current cycle, fines (Thai)
  4. Thai FDA (English) — Manufacture/import of medical devices for commercial purposes: steps 3-7 and fee tables
  5. Thai FDA (English) — News release, 5 March 2026: revised establishment-registration forms for manufacture, import and sale; three notifications B.E. 2569
  6. Thai FDA (English) — Guideline of importation for sale: facility registration, permission to import, License per Invoice, customs, checkpoint
  7. Thai FDA Medical Device Control Division — Product registration overview: risk classification, grouping, ministerial regulations (Thai)
  8. Thai FDA Medical Device Control Division — Product licence and detailed-notification renewal, 2025 cycle announcement (Thai)
  9. MDA Malaysia — Joint announcement, 1 May 2026: full implementation of the MDA-Thai FDA Medical Device Regulatory Reliance Programme
  10. Thai FDA Medical Device Control Division — Transfer of medical device registration dossier documents: application, consent and original-registration withdrawal (Thai)
  11. Andaman Medical — Medical device registration in Thailand overview
  12. Qualtech — Thai FDA Refer and Transfer processes for medical devices
  13. Asia Actual — Thailand medical device registration and approval guidance
  14. Thai FDA Food and Drug Checkpoint Division — Commercial medical-device import steps and checkpoint documents (Thai)

Talk to VEMERIX

VEMERIX is the international brand of Weihai Medison Medical Equipment Co., Ltd., positioned as a Minimally Invasive Surgery Total Solution Platform serving urology, vascular surgery and perioperative care.